18-66509032-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_021153.4(CDH19):c.1791C>T(p.Val597=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0165 in 1,611,996 control chromosomes in the GnomAD database, including 1,333 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.033 ( 192 hom., cov: 32)
Exomes 𝑓: 0.015 ( 1141 hom. )
Consequence
CDH19
NM_021153.4 synonymous
NM_021153.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.769
Genes affected
CDH19 (HGNC:1758): (cadherin 19) This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 18-66509032-G-A is Benign according to our data. Variant chr18-66509032-G-A is described in ClinVar as [Benign]. Clinvar id is 3059447.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.769 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.1791C>T | p.Val597= | synonymous_variant | 11/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.1791C>T | p.Val597= | synonymous_variant | 11/12 | 1 | NM_021153.4 | ENSP00000262150 | P1 | |
CDH19 | ENST00000579658.5 | c.*137C>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/12 | 1 | ENSP00000463085 | ||||
CDH19 | ENST00000540086.5 | c.1459-3730C>T | intron_variant | 2 | ENSP00000439593 |
Frequencies
GnomAD3 genomes AF: 0.0329 AC: 4988AN: 151840Hom.: 189 Cov.: 32
GnomAD3 genomes
AF:
AC:
4988
AN:
151840
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0371 AC: 9295AN: 250678Hom.: 465 AF XY: 0.0339 AC XY: 4586AN XY: 135478
GnomAD3 exomes
AF:
AC:
9295
AN:
250678
Hom.:
AF XY:
AC XY:
4586
AN XY:
135478
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0148 AC: 21642AN: 1460038Hom.: 1141 Cov.: 31 AF XY: 0.0154 AC XY: 11218AN XY: 726202
GnomAD4 exome
AF:
AC:
21642
AN:
1460038
Hom.:
Cov.:
31
AF XY:
AC XY:
11218
AN XY:
726202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0330 AC: 5008AN: 151958Hom.: 192 Cov.: 32 AF XY: 0.0339 AC XY: 2518AN XY: 74266
GnomAD4 genome
AF:
AC:
5008
AN:
151958
Hom.:
Cov.:
32
AF XY:
AC XY:
2518
AN XY:
74266
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
349
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDH19-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at